NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
November 18, 2025 — Parent Greg Scaduto counters vaccine-autism misinformation, explaining why claims linking vaccines to autism are misguided and harmful to public health and families affected by autism.
November 18, 2025 — Oxygen Health Systems installs hyperbaric chamber at Inter Miami for Lionel Messi's team. Learn how HBOT technology used by elite athletes benefits recovery & wellness.
November 18, 2025 — MediKeeper's 2026 workplace wellness trends reveal mental health crisis affecting 25% of workers, AI advancements in health coaching, and combating health misinformation.
November 18, 2025 — XpertDox partners with CHP Berkshires to implement AI medical coding technology, improving revenue cycle operations and coding accuracy for better patient care in underserved communities.
November 18, 2025 — Lifordi Immunotherapeutics secures $112M from Sanofi Ventures to advance LFD-200, a breakthrough antibody-drug conjugate for rheumatoid arthritis treatment without systemic toxicity.
November 17, 2025 — Annovis Bio's Phase 3 Parkinson's study shows buntanetap halts cognitive decline, reverses deterioration in dementia patients with amyloid co-pathology, targeting multiple neurodegenerative proteins.
November 17, 2025 — CNS Pharmaceuticals reports positive Phase 1 data for TPI 287 in glioblastoma treatment, showing blood-brain barrier penetration and tumor responses. Company plans FDA meeting for Phase 2 trial design.
November 17, 2025 — TransCode Therapeutics appoints Dr. Michel Janicot to advance RNA cancer drugs targeting metastatic disease. Learn about TTX-MC138 and the company's oncology pipeline developments.
November 17, 2025 — NRx Pharmaceuticals reports Q3 2025 progress with key regulatory milestones for NRX-100 and NRX-101 depression treatments. Company advances Fast Track and Breakthrough Therapy programs for suicidal depression therapies.
November 17, 2025 — NanoViricides advances NV-387 broad-spectrum antiviral designed to resist viral escape. Targets influenza, RSV, measles & more with novel mechanism. Read latest developments.
November 17, 2025 — Alpha Cognition reports 102% growth in ZUNVEYL pharmacy orders, expanding to 600+ nursing homes. Q3 revenue hits $2.8M with patent protection extended to 2044.
November 17, 2025 — Keep A Breast Foundation celebrates 25th anniversary with Vans Warped Tour return. Historic partnership combines music, breast health education & social impact.
November 17, 2025 — Justin Coffman wins Schenk Law's $2,000 nursing scholarship addressing staffing shortages, pay concerns, and mental health resources in healthcare industry reform efforts.
November 16, 2025 — Mr. Test Prep's hybrid tutoring model combines personalized coaching with mindfulness techniques to boost SAT/ACT scores by 400+ points. 30 years experience, no homework approach.
November 14, 2025 — Comprehensive guide to clenbuterol: Learn about beta-2 agonist mechanisms, global legal status, and key differences from anabolic steroids. Essential reading for researchers.
November 14, 2025 — Research reveals tirzepatide, retatrutide & glutathione peptides advancing metabolic health, tissue regeneration & antioxidant applications through innovative receptor targeting & formulations.
November 14, 2025 — CNS Pharmaceuticals advances TPI 287 for glioblastoma treatment, showing early success in crossing the blood-brain barrier. Phase 2 planning underway for potential 2026 development.
November 14, 2025 — HeartBeam advances 12-lead ECG software toward FDA clearance, partners with HeartNexus for cardiologist review. Revolutionary portable cardiac monitoring technology transforms remote heart care.
November 14, 2025 — UC San Diego study shows GLP-1 drugs like Ozempic and Wegovy reduce colon cancer mortality by 50%. Research reveals potential drug repurposing for cancer treatment.
November 13, 2025 — GeoVax reports Q3 2025 progress on Mpox vaccine, multi-antigen COVID-19 vaccine for immunocompromised patients, and expanded cancer therapy programs with strong clinical data and regulatory advancements.